Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Plos One|March 19, 2014
Analysis of serum miRNA profiles of myasthenia gravis patientsGisela Nogales-Gadea, Alba Ramos-Fransi, Xavier Suárez-Calvet, et al.
Therapeutic Advances in Neurological Disorders|January 26, 2026
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trialJeffrey A Allen, Luis Querol, Niraja Suresh, et al.
Journal of Neuromuscular Diseases|February 4, 2026
Neurologists' decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choicesGerardo Gutiérrez-Gutiérrez, Rocío Gómez-Ballesteros, Adrián Ares, et al.
Neuromuscular Disorders : NMD|July 10, 2022
Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemiaMarta Caballero-Ávila, Rodrigo Álvarez-Velasco, Esther Moga, et al.
Brain : a Journal of Neurology|June 3, 2017
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathyEmilien Delmont, Constance Manso, Luis Querol, et al.
European Journal of Neurology|December 3, 2024
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravisDavid Reyes-Leiva, Álvaro Carbayo, Ana Vesperinas-Castro, et al.
Neurology|February 14, 2014
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgLuis Querol, Gisela Nogales-Gadea, Ricardo Rojas-Garcia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 25, 2015
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteinsLuis Querol, Ricard Rojas-García, Jordi Diaz-Manera, et al.
Neurology|August 8, 2013
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosisLuis Querol, Pamela L Clark, Mary A Bailey, et al.
Journal of Neurology|April 5, 2024
Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravisLaura Martínez-Martínez, Anna Calvet Lacruz, Luis Querol, et al.
Pageof 13